The results of clinical and pulmonary functional evaluation of 24 cats with bronchopulmonary disease and 15 healthy cats are presented. Affected cats had historical evidence of excessive reflexes (coughing, sneezing); physical evidence of airway secretions (crackles), obstruction (wheezing), and increased tracheal sensitivity; radiographic evidence of bronchial and interstitial lung disease; and cytological evidence of airway inflammation or mucous secretions. Bacterial isolates from healthy and affected cats were predominantly Gram-negative rods, indicating that bronchi of cats are not always sterile and that normal flora should be considered in interpreting cultures from cats with suspected bronchopulmonary disease. Cats were grouped according t o relative disease severity based on scored historical, physical, and radiographic abnormalities. The mean (? standard deviation) baseline lung resistance measurement in healthy cats was 28.9 cm H,O/L/s (?6.2 cm H,O/L/s), whereas in mildly, ronchopulmonary disease in the cat represents a group B of poorly understood airway and alveolar space disorder^.'.^ Clinical signs are thought to be due, in part, to underlying airway obstruction. Factors contributing to the development of airway obstruction presumably include development of airway inflammation and mucosal edema, development of airway smooth muscle hypertrophy and constriction, and excessive production or retention of pulmonary secretions. Actual measurements of pulmonary function in cats with bronchopulmonary disease have not been available previously. We obtained pulmonary functional measurements from cats with naturally occurring disease and from clinically healthy cats in an attempt to better assess the presence and degree of airway obstruction in affected cats. Healthy cats were defined as subjects with no known historical or physical findings indicating respiratory disease. A complete clinical database (including historical, physical, and radiographic assessments) was obtained for all cats and also was used to quantify the relative clinical severity of respiratory disease. Measurements of baseline lung resistance (RL) and dynamic lung compliance (Cdyn) were obtained, and airway cytological and microbial culture data were collected. Whenever possible, evaluation also included IV administration of a bronchodilator (BD) to assess reversibility of the airway obstruction, or alternatively, an aerosolized bronchoprovocative challenge to assess the ease with which airway obstruction could be induced (ie, the degree of airway responsiveness [AR] present). Materials and Methods CatsTwenty-four cats with naturally occurring bronchopulmonary disease and 15 clinically healthy cats were evaluated in a cross-sectional study conducted over a 1-year period. The cats with bronchopulmonary disease included 21 cats presented or referred to the University of Illinois Veterinary Medicine Teaching Hospital (UIVMTH) for a variety of clinical signs suggestive of lower respiratory disease. One
This retrospective study reports the presence and incidence of nasal turbinates in the nasopharynx (nasopharyngeal turbinates) in a population of brachycephalic dogs and cats exhibiting signs of upper respiratory disease. Medical records were reviewed for 53 brachycephalic dogs and 10 brachycephalic cats undergoing upper airway endoscopy. Nasopharyngeal turbinates were identified in 21% of brachycephalic animals, including 21% of dogs and 20% of cats. Pugs accounted for 32% of all dogs in the study population and 82% of dogs with nasopharyngeal turbinates. The presence of nasopharyngeal turbinates may play a role in upper airway obstruction in the brachycephalic airway syndrome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.